Last reviewed · How we verify
lidocaine aguettant
At a glance
| Generic name | lidocaine aguettant |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia (PHASE3)
- Efficacy of the Application of Xylocaine Impregnated Compress in Reducing Per-procedural Pain During Ultrasound-guided Infiltration of Trigger Finger (PHASE4)
- Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- lidocaine aguettant CI brief — competitive landscape report
- lidocaine aguettant updates RSS · CI watch RSS
- Assistance Publique Hopitaux De Marseille portfolio CI